Self-Assembled Cationic Nanoparticles Combined with Curcumin against Multidrug-Resistant Bacteria.

Area of Science:

• Materials Science
• Nanotechnology
• Antimicrobial Research

Background:

• Antibiotic resistance poses a significant global health threat, necessitating novel therapeutic strategies.
• Traditional antibiotics often target specific pathways, leading to resistance development.
• There is an urgent need for new antibacterial agents with unique mechanisms of action.

Purpose of the Study:

• To develop and characterize a novel nanocomposite, PNs-Cur, for combating antibiotic-resistant bacteria.
• To evaluate the antibacterial efficacy, toxicity, and resistance development potential of PNs-Cur.
• To elucidate the antibacterial mechanism of PNs-Cur.

Main Methods:

• Fabrication of PNs-Cur via ring-opening polymerization and self-assembly of curcumin.
• Characterization using UV-vis, SEM, DLS, and molecular modeling.
• In vitro and in vivo antibacterial assays against various pathogens, including drug-resistant strains.
• Toxicity assessments and bacterial passage studies to evaluate resistance emergence.

Main Results:

• PNs-Cur, a positively charged nanocomposite (289.6 nm), was successfully synthesized and characterized.
• Demonstrated broad-spectrum antibacterial and antifungal activity with MIC values of 8-32 μg/mL.
• Showed potent in vivo antibacterial efficacy in infected mice with low toxicity.
• Crucially, PNs-Cur did not induce drug-resistant bacterial strains even after 21 passages.

Conclusions:

• PNs-Cur is a promising antibacterial material with a unique mechanism involving membrane disruption and apoptosis induction.
• Its ability to avoid resistance development makes it a valuable candidate for combating prevalent bacterial infections.
• This study presents a novel strategy for developing efficient antibacterial agents against resistant pathogens.